AUCTORES
Globalize your Research
Review Article | DOI: https://doi.org/10.31579/2693-7247/044
1Assistant professor of Medicine, Unit-3, Lahore General Hospital / PGMI / AMC. Pakistan.
2University of Lahore, Pakistan.
3Associate Professor & Head of Department of Urology, University College of Medicine, University of Lahore
*Corresponding Author: Kashif Aziz Ahmad, Assistant professor of Medicine, Unit-3, Lahore General Hospital / PGMI / AMC. Pakistan.
Citation: Kashif Aziz Ahmad, Saleha Akram Nizami, Muhammad Haroon Ghous. (2022) Coronavirus - Drug Discovery and Therapeutic Drug Monitoring Options, J. Pharmaceutics and Pharmacology Research, 5(2); DOI: 10.31579/2693-7247/044
Copyright: © 2022 Kashif Aziz Ahmad, This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Received: 09 November 2021 | Accepted: 13 December 2021 | Published: 05 January 2022
Keywords: drug discovery; therapeutic drug; COVID-19
COVID-19 is basically a medium size RNA virus and the nucleic acid is about 30 kb long, positive in sense, single stranded and polyadenylated. The RNA which is found in this virus is the largest known RNA and codes for a large polyprotein. In addition, coronaviruses are capable of genetic recombination if 2 viruses infect the same cell at the same time. SARS-CoV emerged first in southern China and rapidly spread around the globe in 2002–2003. In November 2002, an unusual epidemic of atypical pneumonia with a high rate of nosocomial transmission to health-care workers occurred in Foshan, Guangdong, China. In March 2003, a novel CoV was confirmed to be the causative agent for SARS, and was thus named SARS-CoV. Despite the report of a large number of virus-based and host-based treatment options with potent in vitro activities for SARS and MERS, only a few are likely to fulfil their potential in the clinical setting in the foreseeable future. Most drugs have one or more major limitations that prevent them from proceeding beyond the in vitro stage. First, many drugs have high EC50/Cmax ratios at clinically relevant dosages
The history of corona virus family is very old, it begins in 1965 when Tyrrell and Bynoe found that there was a virus family who damage the respiratory pathway. This virus was named as B814 in that time. It was transmitted from animals to humans. Now, in 2020 there is a virus COVID-19 which is also belongs to the family of corona virus is infected the whole world. People all around the world facing the situation of pandemic. This virus effected the whole world and do not believe in racism.
COVID-19 is basically a medium size RNA virus and the nucleic acid is about 30 kb long, positive in sense, single stranded and polyadenylated. The RNA which is found in this virus is the largest known RNA and codes for a large polyprotein. In addition, coronaviruses are capable of genetic recombination if 2 viruses infect the same cell at the same time.
The most common symptoms of COVID-19 is cold, flu, fever and infection in lungs. There are different stages in the attacking of this virus. At stage one and at the start patient just feel flu and temperature just like common cold and flu. But after seven days it becomes more worse and patient feels shortness of breath and dry cough. At advanced stage the patients become also suffered from pneumonia. There is no vaccine and antiviral therapy until now.
In this short communication we will talk about current situation of COVID-19 in Pakistan. It was basically starts from China from December 2019, when there was a person who died in Wuhan (a city of China) due to an unknown virus. What started as an epidemic mainly limited to China has now become a truly global pandemic. There have now been over 392,331 confirmed cases and 17,156 deaths, according the John Hopkins University Covid-19 dashboard, which collates information from national and international health authorities. The disease has been detected in more 196 countries and territories, with Italy, the US and Spain experiencing the most widespread outbreaks outside of China. There were 438,441 cases from which 19,650 died and 111,877 were recovered all around the world.
SARS-CoV started first in southern China and quickly spread the world over in 2002–2003. In November 2002, an irregular pandemic of atypical pneumonia with a high pace of nosocomial transmission to human services laborers happened in Foshan, Guangdong, China. In March 2003, a novel CoV was affirmed to be the causative specialist for SARS, and was in this manner named SARS-CoV. The disengagement of a novel βCoV from a patient in Jeddah, Saudi Arabia, who passed on of extreme pneumonia and multi-organ disappointment in June 2012, was first detailed in September 2012. At first named 'human coronavirus Erasmus Medical Center', the infection was later renamed MERS-CoV by global accord, and the sickness was called Middle East respiratory syn-drome (MERS). Review examination of a group of nosocomial cases in April 2012 in Jordan affirmed that MERS-CoV was likewise liable for that flare-up. In the course of recent years, MERS-CoV has kept on spreading inside and past the Middle East, and there are progressing reports of inconsistent cases and network and social insurance related groups of tainted people in the Middle East, particularly in Saudi Arabia and the United Arab Emirate. Travel-related cases and groups have likewise been progressively given an account of different mainlands. Starting at 9 October 2015, 1,593 lab affirmed instances of MERS, including 568 passings, have been accounted for to the World Health Organization.
Non-structural proteins Structural and accessory proteins
The typical coronavirus (CoV) genome is a single‑stranded, non‑segmented RNA genome, which is approximately 26–32kb. It contains 5ʹ‑methylated caps and 3ʹ‑polyadenylated tails and is arranged in the order of 5ʹ, replicase genes, genes encoding structural proteins (spike glycoprotein (S), envelopeprotein (E), membrane protein(M) and nucleocapsid protein (N)), poly adenylated tail and then the 3ʹ end. The partially overlapping 5ʹ‑terminal open reading frame 1a/b (ORF1a/b) is within the 5ʹ two‑thirds of the CoV genomeand encodes the large replicase poly protein 1a (pp1a)and pp1ab.
Approachesto anti-CoV drugscreening
The main two human-pathogenic CoVs known before the SARS pestilence were HCoV-229E and HCoV-OC43, which as a rule because self-constraining upper respiratory tract contaminations. Along these lines, analysts and examination offices, particularly those associated with antiviral turn of events, were underprepared when SARS-CoV out of nowhere emerged in 2003. In this manner, three general methodologies were utilized to find potential enemy of CoV treatment alternatives for human-pathogenic CoVs particularly SARS-CoV and the rising MERS-CoV.
The main way to deal with sedate revelation is to test existing wide range antiviral medications that have been utilized to treat other viral diseases by utilizing standard examines that measure the impacts of these medications on the cytopathi city, infection yield and plaque development of live and additionally pseudo composed CoVs. Instances of medications distinguished utilizing this methodology incorporate interferon alfa, interferon beta, interferon gamma, ribavirin and inhibitors of cyclophilin. These medications have the undeniable preferred position of being promptly accessible with known pharmacokinetic and pharmacodynamic properties, symptoms and dosing regimens. Nonetheless, they don't have explicit enemy of CoV impacts and might be related with serious antagonistic impacts. The second enemy of CoV medicate revelation approach includes the screening of substance libraries involving huge quantities of existing mixes or databases that contain data on transcriptional marks in various cell lines. This methodology gives quick, high-throughput screening of numerous promptly accessible aggravates that would then be able to be additionally assessed by hostile to viral tests. Different classes of medications have been distinguished in these medication repurposing programs, including numerous that have significant physiological as well as immunological impacts, for example, those that influence synapse guideline, the estrogen receptor, kinase flagging, lipid or sterol digestion, protein handling and DNA amalgamation or fix.
Nucleosides and nucleotides are the building blocks of viral nucleic acids. Medications that target nucleosides or nucleotides as well as viral nucleic acids by and large have expansive range movement against a wide scope of CoVs and different viruses. Mycophenolate mofetil is an enemy of dismissal tranquilize that represses inosine monophos-phate dehydrogenase and the union of guanine monophosphate. The dynamic compound, mycophenolic corrosive, displays antiviral action in vitro against different viruses, including hepatitis B infection (HBV), hepatitis C infection (HCV) and arbo viruses. Mycophenolic corrosive was distinguished as a potential enemy of MERS-CoV sedate utilizing high-throughput screening and has powerful enemy of MERS-CoV action in vitro122. In any case, an ensuing report in a non-human primate model demonstrated that MERS-CoV-tainted normal marmosets rewarded with mycophenolate mofetil had a more regrettable result with progressively extreme illness and higher viral loads in necropsied lung and extra pneumonic tissues than untreated creatures. Renal transplant beneficiaries who were on upkeep mycophenolate mofetil treatment additionally created serious or deadly MERS. Subsequently, the standard measurement of mycophenolate mofetil monotherapy is probably not going to be helpful for prophylaxis or treatment of CoV contaminations.
Advancement of MERS-CoV immunizations
Quick diagnostics and compelling immunizations are regularly correlative to antiviral treatment in the control of pandemics brought about by developing viruses. In spite of the fact that there has not been any new human SARS case for more than 10 years, inconsistent cases and groups of MERS keep on happening in the Middle East inferable from the diligence of zoonotic sources in endemic territories, and these cases spread to different areas. Powerful MERS-CoV antibodies are basic for intruding on the chain of transmission from creature stores and contaminated people to helpless hosts. Live-constricted antibodies, which have been recently assessed in creature models for SARS, may be related with dispersed disease in resistant traded off patients. Inactivated antibodies may be related with immunopathology during creature challenge. These are un great methodologies for MERS antibody advancement on the grounds that a considerable extent of patients with serious MERS have comorbidities or fundamental resistant bargaining conditions. Other immunization systems for MERS that utilization DNA plasmids, viral vectors, nanoparticles, infection like particles and recombinant protein subunits are being developed and some have been assessed in creature models. The accessibility of a sheltered and powerful MERS-CoV antibody for dromedary camels and non-invulnerable people at high danger of camel contact in endemic locales, for example, the Middle East and the more prominent Horn of Africa would be a significant measure for controlling the progressing pandemic.
Reasonable creature models are particularly significant for testing hostile to CoV drugs in light of the fact that the vast majority of these medications have not been utilized in people. As opposed to the set number of creature models set up for the mellow diseases brought about by HCoV-229E, HCoV-OC43, HCoV-NL63 and HCoV-HKU1, different little creature and non-human primate models have been assessed for investigations of the pathogenesis and treatment of SARS and MERS.
Despite the report of a large number of virus-based and host-based treatment options with potent in vitro activities for SARS and MERS, only a few are likely to fulfil their potential in the clinical setting in the foreseeable future. Most medications have at least one significant impediments that keep them from continuing past the in vitro stage. In the first place, numerous medications have high EC50/Cmax proportions at clinically significant measurements. Instances of such medications incorporate cyclosporine, chlorpromazine and interferon alfa. Second, some have extreme symptoms or cause immunosuppression. For instance, the utilization of high-portion ribavirin might be related with haemolytic iron deficiency, neutropenia, teratogenicity and cardiorespiratory trouble. MERSCoV-contaminated basic marmosets rewarded with mycophenolate mofetil built up a deadly disease with significantly higher viral burdens in their lungs and extra aspiratory tissues than untreated controls did128. Operators focusing on have flagging pathways or receptors may instigate immunopathology. Moreover, the absence of a solid medication conveyance strategy in vivo is especially tricky for siRNAs and different operators that have not been recently utilized in people.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
